Pfizer buys cancer drug company for $14bn

Pharmaceutical giant Pfizer has agreed to buy cancer drug-maker Medivation.

The deal is worth $14 billion.

Nick Harper reports from New York.

IN: "The acquisition of..."
OUT:  SOC
DUR: 35 seconds

AIR: http://www.fsnradionews.com/feeds/0822pfizer-nh-air.mp3
ARN: http://www.fsnradionews.com/feeds/0822pfizer-nh-arn.mp3
FM4: http://www.fsnradionews.com/feeds/0822pfizer-nh-fm4.mp3
GENERIC: http://www.fsnradionews.com/feeds/0822pfizer-nh-gen.mp3
ICRT: http://www.fsnradionews.com/feeds/0822pfizer-nh-icrt.mp3
NIGERIA: http://www.fsnradionews.com/feeds/0822pfizer-nh-von.mp3
938LIVE: http://www.fsnradionews.com/feeds/0822pfizer-nh-938.mp3
RNZ: http://www.fsnradionews.com/feeds/0822pfizer-nh-rnz.mp3
SRN: http://www.fsnradionews.com/feeds/0822pfizer-nh-srn.mp3
VATICAN: http://www.fsnradionews.com/feeds/0822pfizer-nh-vat.mp3
ZIZ: http://www.fsnradionews.com/feeds/0822pfizer-nh-ziz.mp
SABC: http://www.fsnradionews.com/feeds/0822pfizer-nh-sabc.mp